
A new study has revealed that problems such as nail separation and hair loss are more common in those who use GLP-1 group weight loss drugs used in the treatment of obesity and type 2 diabetes.
A new study conducted in France, the USA, Brazil and Mexico revealed that problems such as nail separation and hair loss are more common in those who use GLP-1 group weight loss drugs.
AI-generated summary
GLP-1 group drugs are widely used in the treatment of obesity and type 2 diabetes.
A new study on GLP-1 group weight loss drugs used in the treatment of OBESITY and type 2 diabetes revealed that problems such as nail separation and hair loss are more common in people using the drugs.
In the research conducted with the participation of 2 thousand people in France, USA, Brazil and Mexico, it was determined that the nails separated from the nail bed in 39 percent of those who used weight loss drugs. For those who did not use medication, this rate remained at 9 percent. The rate of people experiencing color change in their nails reached 46 percent in those using medication, while it was recorded as 17 percent in the other group.
HAIR IS ALSO LOOSING

Minister of Health Kemal Memişoğlu, drawing attention to the tobacco use rates in Türkiye, announced that new regulations that will reduce the visibility of cigarettes and control their sales will soon come to the Parliament.

Minister of Health Kemal Memişoğlu announced that within the scope of the fight against smoking, identity and age verification will be mandatory in sales and products will be no longer visible.

Minister of Health Memişoğlu announced that they are working on a system that will allow chronic patients to buy medicine directly from the pharmacy without having to re-prescribe it during the medicine report period.

Minister of Health Kemal Memişoğlu announced that they are working on a new system that will allow chronic patients to buy their medications directly from the pharmacy without having to go to the doctor every time during the medication report.
Minister of Health Kemal Memişoğlu announced that they are working on a new system that will allow registered medicines to be purchased from the pharmacy without going to the doctor, as long as there is no change in treatment. In addition, home health services and palliative care capacity were expanded.

In Türkiye, neuromuscular diseases appear individually rare, but together they constitute a significant health burden affecting millions of people. It is estimated that the number of patients living with ALS is approximately 10 thousand, and the number of patients living with SMA is over 3 thousand. Thanks to genetic therapies, children with SMA can now reach older ages, and early treatment initiation results are markedly improved.